Peer-reviewedLicence not statedClinical Pharmacology and Therapeutics
Dapagliflozin vs. Acetazolamide in Patients With Acute Heart Failure: A Randomized Controlled Trial (CHOICE‐AHF)
- 1Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy Mansoura University Mansoura Egypt
- 2Department of Pharmacy Practice, Faculty of Pharmacy Delta University for Science and Technology Gamasa Egypt
- 3Cardiology Department, Faculty of Medicine Mansoura University Mansoura Egypt
Related
- Early Initiation of Dapagliflozin in Acute Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Real-world utilization, safety, and observed clinical outcomes of dapagliflozin among Sudanese patients with heart failure: a multicenter retrospective cohort study
- Improving Dapagliflozin Dosing in Heart Failure Through System-Level Quality Improvement
- Global Perspective on the Outcomes of Dietary Pattern and Nutrient-Based Interventions for Heart Failure: A Systematic Review of Randomized Controlled Trials
- Wearable biofeedback devices for remote rehabilitation of elderly patients with arthritis and fibromyalgia: a randomized controlled trial protocol
BibTeX
@article{sharaf2026dapagliflozin,
title = {{Dapagliflozin vs. Acetazolamide in Patients With Acute Heart Failure: A Randomized Controlled Trial (CHOICE‐AHF)}},
author = {Hossam Sharaf and Moheb Wadie and Noha O. Mansour and Mohamed E. E. Shams},
journal = {Clinical Pharmacology and Therapeutics},
year = {2026},
month = nov,
doi = {10.1002/cpt.70540},
url = {https://doi.org/10.1002/cpt.70540},
}
RIS
TY - JOUR
TI - Dapagliflozin vs. Acetazolamide in Patients With Acute Heart Failure: A Randomized Controlled Trial (CHOICE‐AHF)
AU - Hossam Sharaf
AU - Moheb Wadie
AU - Noha O. Mansour
AU - Mohamed E. E. Shams
PY - 2026
DA - 2026/11/03
JO - Clinical Pharmacology and Therapeutics
DO - 10.1002/cpt.70540
UR - https://doi.org/10.1002/cpt.70540
SN - 0009-9236
SN - 1532-6535
ER -